戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              SHED are not only derived from a very accessible tissue
2                                              SHED were identified to be a population of highly prolif
3                                              SHEDs were treated with P(i).
4 , SCAP (stem cells from apical papilla), and SHED (stem cells from human-exfoliated deciduous teeth)
5 ) as a specific interacting partner for both SHED and transmembrane HEMO proteins.
6 bilized SHED group compared with the control SHED.
7  termed here the split helical dimerization (SHED) region.
8  cleft is occluded, and its newly identified SHED region may promote an unexpected dimerization mode.
9 ) treatment is able to significantly improve SHED-mediated osteogenic differentiation and immunomodul
10 eatment is a practical approach to improving SHED-based cell therapy.
11  but inhibited adipogenic differentiation in SHED.
12                             Mechanistically, SHED transplantation induces activated T-cell apoptosis
13 buted to both endothelial differentiation of SHED and recruitment of host blood vessels.
14 ylation and inhibited the differentiation of SHED into endothelial cells.
15 that regulate endothelial differentiation of SHED.
16                                  Exposure of SHED to EGM2-MV supplemented with VEGF induced potent ac
17 a-catenin cascade, leading to improvement of SHED-mediated bone regeneration, and also upregulates TE
18 RT/FASL signaling, leading to improvement of SHED-mediated T-cell apoptosis and ameliorating disease
19 lpha stabilization enhances cell survival of SHED through modulating various target genes and potenti
20 ere we show that systemic transplantation of SHED via the tail vein ameliorates ovariectomy (OVX)-ind
21 ed structural similarities between the PEAK1 SHED region and the C-terminal extension of the Parkinso
22 carbonate-substituted mineral and with SCAP, SHED, and GF cells creating a less crystalline material
23                     In vivo, VEGFR1-silenced SHED seeded in tooth slice/ scaffolds and transplanted i
24  secreted from the cell surface as a soluble SHED form which can be detected in pregnant women blood.
25 ough RNA sequencing in HIF-1alpha-stabilized SHED and demonstrated its essential role in HK2 and Glut
26 n were detected in the HIF-1alpha-stabilized SHED group compared with the control SHED.
27 aspase 3 expression in HIF-1alpha-stabilized SHED in hypoxic conditions.
28                        HIF-1alpha-stabilized SHED were encapsulated in PuraMatrix hydrogel, injected
29                                  In summary, SHED-mediated T-cell apoptosis via a FasL/Fas pathway re
30 cells from human exfoliated deciduous teeth (SHED) are a unique postnatal stem cell population, posse
31  Stem cells from exfoliated deciduous teeth (SHED) exposed to endothelial growth medium (EGM-2MV) sup
32 cells from human exfoliated deciduous teeth (SHED) for evaluation of gene/protein function, WNT signa
33  Stem cells from exfoliated deciduous teeth (SHED) possess multipotent differentiation and immunomodu
34 cells from human exfoliated deciduous teeth (SHED) were preconditioned to a hypoxic condition by hypo
35  stem cells from exfoliated deciduous teeth (SHED), periodontal ligament stem cells (PDLSCs), stem ce
36 lated from human exfoliated deciduous teeth (SHED).
37 cells from human exfoliated deciduous teeth (SHED)].
38 tabilized by one pseudokinase domain and the SHED domain of the PEAK3 dimer.
39                                         This SHED-mediated immunomodulation rescues OVX-induced impai
40               After in vivo transplantation, SHED were found to be able to induce bone formation, gen
41              However, the mechanism by which SHED treat immune diseases is not fully understood.